MAJORS MICHAEL CLAY 4
4 · GLOBE LIFE INC. · Filed Feb 9, 2026
Research Summary
AI-generated summary of this filing
Globe Life (GL) EVP Michael Majors Exercises Options, Sells 30,000 Shares
What Happened
- Michael Clay Majors, EVP & Chief Strategy Officer of Globe Life (GL), exercised options/conversions on Feb 6, 2026 to acquire 30,000 shares (27,000 at $100.74 and 3,000 at $98.32) for a total exercise cost of $3,014,940.
- On the same day he sold the 30,000 shares in multiple open-market transactions, generating total proceeds of $4,406,824 (sales executed at prices reported between $145.605 and $148.79 per share).
- This pattern—exercise of derivatives followed by immediate sale—is consistent with a cashless or sell-to-cover exercise (insider converted options into shares and disposed of the resulting shares).
Key Details
- Transaction date: February 6, 2026; Form 4 filed February 9, 2026 (appears to be timely).
- Exercises: 27,000 shares @ $100.74 ($2,719,980) and 3,000 shares @ $98.32 ($294,960) — total $3,014,940.
- Open-market sales: 11,581 @ $146.04, 13,510 @ $147.18, 3,488 @ $147.92, 1,421 @ $148.63 — total proceeds $4,406,824. Footnotes list sales price groupings: $145.605–$146.42; $146.62–$147.475; $147.55–$148.465; $148.48–$148.79. F2 notes detailed per-price share counts are available on request to the SEC/issuer/shareholders.
- Shares owned after the transactions: not specified in the provided filing excerpt.
- Prior entry (Feb 6, 2025) shows exercise/conversion of 27,000 and 3,000 shares reported with $0 proceeds (reported as derivative dispositions) — see filing for details.
Context
- For retail investors: exercising options and immediately selling the resulting shares is a common way for insiders to cover exercise costs, taxes, or diversify and does not necessarily signal a judgment about the company’s outlook. This filing documents a derivative exercise (M) followed by open-market sales (S); no 10b5-1 plan or other arrangement is referenced in the noted footnotes.
Insider Transaction Report
Form 4
MAJORS MICHAEL CLAY
EVP - Chief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock
2026-02-06$100.74/sh+27,000$2,719,980→ 74,066 total - Exercise/Conversion
Common Stock
2026-02-06$98.32/sh+3,000$294,960→ 77,066 total - Sale
Common Stock
[F1][F2]2026-02-06$146.04/sh−11,581$1,691,315→ 65,485 total - Sale
Common Stock
[F2][F3]2026-02-06$147.18/sh−13,510$1,988,376→ 51,975 total - Sale
Common Stock
[F2][F4]2026-02-06$147.92/sh−3,488$515,936→ 48,487 total - Sale
Common Stock
[F2][F5]2026-02-06$148.63/sh−1,421$211,197→ 47,066 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-02-06−27,000→ 0 totalExercise: $100.74From: 2023-02-26Exp: 2027-02-26→ Common Stock (27,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-02-06−3,000→ 34,000 totalExercise: $98.32From: 2024-02-24Exp: 2028-02-24→ Common Stock (3,000 underlying)
Holdings
- 0(indirect: N/A)
Common Stock
Footnotes (5)
- [F1]Sales at prices ranging from $145.605 per share to $146.42 per share.
- [F2]Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
- [F3]Sales at prices ranging from $146.62 per share to $147.475 per share.
- [F4]Sales at prices ranging from $147.55 per share to $148.465 per share.
- [F5]Sales at prices ranging from $148.48 per share to $148.79 per share.
Signature
Michael C. Majors, By /s/ Chris T. Moore, Attorney-in-fact|2026-02-09